Vector BioMed Presentation: Improving Affordability and Access of CAR-T Cell and Other Gene Modified Cell Therapies
Thursday, May 30, 2024 01:00 PM - 01:15 PM
Exhibit Hall - Theatre A
Global Showcase Presentation
Presenter
• Boro Dropulic, PhD, MBA, Founder and CEO of Vector BioMed and Caring Cross, USA
Autologous CAR-T cell therapies are effective, but their high price restricts access. Development of affordable materials for CAR-T cell manufacturing Point-of-Care Manufacturing reduces cost and improves access A pipeline of CAR-T cell and other products in development to serve the point-of-care model in partnership with hospitals.
• Boro Dropulic, PhD, MBA, Founder and CEO of Vector BioMed and Caring Cross, USA
Autologous CAR-T cell therapies are effective, but their high price restricts access. Development of affordable materials for CAR-T cell manufacturing Point-of-Care Manufacturing reduces cost and improves access A pipeline of CAR-T cell and other products in development to serve the point-of-care model in partnership with hospitals.
SPONSORED BY:
